In December 2025, Dr. Reddy’s Laboratories expanded its U.S. hospital portfolio with the launch of Phenylephrine Hydrochloride in 0.9% Sodium Chloride Injection IV Bag, 20 mg/250 mL in a pack of 5 Bags (NDC 43598-182-05), the first FDA-approved Phenylephrine IV Solution bag available in the U.S. market.
Manufactured in easy-to-use semi-rigid polypropylene bags, the bag presentation features a fully collapsible and convenient one-handed carrying design.
Phenylephrine Hydrochloride in 0.9% Sodium Chloride Injection IV Bag is a preservative-free formulation available in a 20 mg/250 mL ready-to-use presentation and offers a 36-month shelf life.
Supported by Dr. Reddy’s integrated global manufacturing and supply network, the product is readily available to all customers, reinforcing the Company’s ability to reliably deliver important medicines to the U.S. healthcare system.
RDY-1026-916
